Jerusalem, Israel

Giora Beit-Yaakov

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giora Beit-Yaakov: Innovator in Renal Denervation Technologies

Introduction

Giora Beit-Yaakov is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical technology, particularly in the area of renal denervation. His innovative work focuses on developing devices and methods that enhance the effectiveness of renal sympathetic denervation treatments.

Latest Patents

Giora Beit-Yaakov holds a patent for "Devices and methods for renal denervation and assessment thereof." This invention relates to devices and methods for intravascular denervation, specifically targeting renal denervation. The patent describes an intravascular catheter designed for ultrasonic ablation of tissue, which includes a plurality of piezoelectric transceivers. Additionally, the invention features an intravascular distancing device that ensures a minimal distance between the ultrasound emitting element and the tissue, such as the blood vessel wall. The patent also addresses the assessment of renal sympathetic denervation treatment effectiveness by processing echo signals to characterize the physical and mechanical properties of blood vessels.

Career Highlights

Giora Beit-Yaakov is associated with Cardiosonic Ltd., a company that focuses on innovative medical technologies. His work at Cardiosonic Ltd. has been instrumental in advancing the field of renal denervation, contributing to improved treatment options for patients with hypertension and related conditions.

Collaborations

Giora has collaborated with notable professionals in his field, including Ariel Sverdlik and Or Shabtay. These collaborations have further enhanced the development and application of his innovative technologies.

Conclusion

Giora Beit-Yaakov's contributions to renal denervation technologies exemplify the impact of innovation in medical science. His patent and work at Cardiosonic Ltd. highlight the importance of advancing treatment methods for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…